Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

FPP and Indoco Sign Licensing and Supply Agreement


Florida Pharmaceutical Products, LLC (FPP), a pharmaceutical company involved in the Development, Sales, Marketing and Distribution of Generic Pharmaceuticals and Indoco Remedies Limited (Indoco), a company engaged in the Development, Manufacturing and Licensing of pharmaceuticals are pleased to announce the signing of an agreement for the Licensing, Supply and Distribution of a USFDA approved ANDA for an Ophthalmic Solution, developed & filed by Indoco and approved by the FDA, scheduled to launch Q1 2021.

The product has sales of approximately $18 million according to IQVIA™. The ANDA product will be sold and distributed by FPP in the FPP Label within the US. “We are excited to work with Indoco on this opportunity and look forward to launching this Ophthalmic product” said Larry J. Lapila, President of FPP. The ANDA will be manufactured by Indoco.

“Indoco is happy to partner with FPP and we will extend our complete support to FPP for gaining market share for this product” said Aditi Kare Panandikar, Managing Director – Indoco Remedies Ltd.

About Florida Pharmaceutical:

Florida Pharmaceutical Products, LLC (FPP) is a Boca Raton based pharmaceutical company involved in the development of Generic Pharmaceuticals seeking to gain approval and/or license of niche generic products in a broad range of therapeutic areas for marketing and distribution in the US.

About Indoco:

Indoco Remedies Ltd., headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries. Indoco, a USD 145 million Company, employs over 5,500 people, including more than 300 skilled scientists.

The Company has 9 manufacturing facilities, 6 for FDFs and 3 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. The facilities have been approved by most of the Regulatory Authorities, including USFDA and UK-MHRA. Indoco develops and manufactures a wide range of pharmaceutical products for the Indian and international markets.

Share article on social media or email:

New Reseller Program Offers Partners the Opportunity to Sell, Install & Support Healthcare’s Most Innovative Patient Communication Products


News Image

“We have launched Align to accelerate healthcare delivery organizations’ access to these technologies through the partners they already know and trust.”

Critical Alert announced today the launch of its Align Reseller Program providing partners the opportunity to sell, install and support the company’s innovative product lines. Align is open to North American Value-Added Resellers (VAR), Systems Integrators, Service Providers, Solution Providers and OEMs committed to helping healthcare delivery organizations accelerate their transformation into real-time health systems (RTHS).

Align Resellers benefit from Critical Alert’s 30 years of innovation with cutting-edge solutions offered as part of the CommonPath Enterprise platform including: next-generation nurse call, alarm management, clinical workflow optimization, nurse call command center, real time location systems (RTLS), clinical communication and collaboration, and patient experience analytics.

Qualified resellers are certified to sell, install and configure Critical Alert products on a solution-by-solution basis, affording them the opportunity to focus on those products that best match their core competency. The multi-tier program offers additional benefits including deal registration, training and marketing resources.

Critical Alert views Align resellers as an extension of its sales team and places tremendous value on the role they play in the execution of the company’s go-to-market strategy and overall success. With the new program, Critical Alert demonstrates its commitment to the channel, collaboration with resellers and will work continuously to engage and enhance value-based solutions with their client end-users within clinical, IT and operations leadership.

“The challenges our healthcare systems are facing today are astounding. To continue to be viable, they must fast-track adoption of real time health system technologies” stated Wil Lukens, vice president of sales at Critical Alert. “We have launched Align to accelerate healthcare delivery organizations’ access to these technologies through the partners they already know and trust,” continued Lukens.

Interested parties should click here: http://criticalalert.com/align-partner-program/

About Critical Alert

Critical Alert offers a cost-effective solution set of enterprise-class, software-based products, services and strategies that enable hospitals and healthcare enterprises to give patients a voice, empower clinical staff with actionable intelligence, and unburden their support and IT teams. CommonPath Enterprise, our software-driven patient communications platform, is FDA-cleared as a Class II Medical Device and includes UL-1069 nurse call, middleware for alarm management & event notification, patient experience & behavior monitoring, advanced clinical analytics, and a portfolio of partner and device integrations.

For more information, visit: http://criticalalert.com/ and follow on LinkedIn.

Critical Alert is a trademark of Critical Alert. All other product or service names are the property of their respective owners.

Share article on social media or email:

Southern Medical Association Installs New President


SMA is my family of medicine. The place where I started, and have remained connected throughout my career.

The Southern Medical Association (SMA) is proud to announce the installation of Christopher R. Morris, MD, as President for 2020-2021. Dr. Morris was installed Saturday afternoon at the Annual Assembly. Established in 1906, SMA is a multidisciplinary, interprofessional medical association committed to providing physicians with education and information in order to provide quality patient care and lead the discussion on healthcare reform.

Dr. Morris is the first Rheumatologist to serve as President. He is board certified in Rheumatology with more than 20 years experience. He received his undergraduate degree at Tulane University in New Orleans, Louisiana, and received his medical degree from the Universidad Autonoma de Guadalajara, Guadalajara, Jalisco, Mexico. He completed his Internship and Residency at the University of Tennessee Medical Center in Knoxville, and Rheumatology fellowship at the Medical College of Georgia in Augusta. Before entering private practice, he was a Clinical Assistant Professor of Medicine at East Tennessee State University in Johnson City, Tennessee, where he was involved in numerous research projects.

Dr. Morris has been a member of SMA since he was a resident. He has served in many leadership roles, and as a member of the Board for the last several years. In his acceptance speech, Dr. Morris said, “SMA is my family of medicine. The place where I started, and have remained connected throughout my career. I ask you to join me this year, in helping make our family bigger and stronger.”

Dr. Morris has a very distinguished career serving in leadership. He has served in many roles during his member service with SMA including representing his state as Councilor and serving on several Education Design Groups. He has served on six committees for the American College of Rheumatology, currently serving on the Insurance subcommittee, which advocates for patients with rheumatologic diseases.

Dr. Morris is married to Jane Alison Jackson Morris, and has two children Christopher Richard Jr. and Amanda Kathleen. His hobbies include being a life master in bridge, and Order of Merlin in the International Brotherhood of Magicians.

Southern Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Visit http://sma.org for organizational and membership information. Visit http://sma.org for organizational and membership information.

Share article on social media or email:

The Journal of Invasive Cardiology Announces Shift to All-Digital Format, Expanded Content


The move to a digital-only format reflects our continued commitment to not only report on innovations in the medical community, but to stay up to date on the trends and advancements in the world of scientific publishing.

The Journal of Invasive Cardiology (JIC), a peer-reviewed and indexed journal devoted to the non-surgical treatment of cardiovascular disease, and part of the HMP Global CardioVascular Learning Network, a premier digital information destination offering practical, relevant content and education, today announced that it will move exclusively online, beginning in January of 2021.

The journal provides a direct conduit to the latest innovations in clinical research and practice, concentrating on real-world outcomes around the use of therapeutic devices in cardiovascular and structural heart disease, drugs used in the cath lab and in post-PCI therapy, advances in imaging, and comparisons of treatment modalities. The all-digital format will contain everything readers have come to expect from JIC, delivered for an increasingly on-demand world. Plans for the new version include greater flexibility, new options for receiving important news updates, and expanded content.

“With this shift, JIC continues its mission to help cardiovascular practitioners make sense of the clinical significance of research and how it can be immediately applied in day-to-day patient care, while also demonstrating recognition that the landscape of information delivery has changed – educationally and environmentally,” said Deepak L. Bhatt, MD, MPH, Editor-in-Chief, JIC, Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital, and Professor of Medicine at Harvard Medical School in Boston. “We will further amplify the JIC mission with supplementary journal content beyond print, including an enhanced focus on video and podcasts.”

“The move to a digital-only format reflects our continued commitment to not only report on innovations in the medical community, but to stay up to date on the trends and advancements in the world of scientific publishing,” said Laurie Gustafson, Executive Editor. “We look forward to this launch and to the expanded content we are rolling out that will further benefit global cardiovascular research and practice.”

To learn more about the Journal of Invasive Cardiology, visit invasivecardiology.com.

About HMP Global

HMP Global is the force behind Healthcare Made Practical – and is a multichannel leader in health care events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global health care community across a range of therapeutic areas. The CardioVascular Learning Network, also features the well-respected publications Cath Lab Digest, Vascular Disease Management, and EP Lab Digest, as well as a repository of in-person and virtual continuing medical education, including the International Symposium on Endovascular Therapy (ISET), the Amputation Prevention Symposium (AMP) and AMP Europe, and the Leipzig Interventional Course (LINC), the premier interdisciplinary live course in Leipzig, Germany, focusing on endovascular intervention. For more information, visit hmpglobal.com.

Share article on social media or email:

Advancements TV Series to Focus on Innovations in Molecular Laboratory Testing


News Image

“These innovative testing facilities provide opportunities to identify mutations and deletions of genes, allowing people to reduce their risk of disease and detect diseases earlier.”

Advancements with Ted Danson will focus on recent developments in molecular and genetic capabilities in an upcoming episode, scheduled for 1Q/2021.

Currently, technology and scientific research are pushing molecular and genetic capabilities forward, while the world begins to discover the importance behind the individual components of our genetic code.

This segment will explore NS Genomics’ state-of-the-art molecular and next generation sequencing laboratories (Natural State Labs) and will uncover how they are helping clinicians and patients make the most of these individual genetic differences.

Audiences will see how by partnering with leading manufacturers of genotyping technologies, NS Genomics is able to identify unique variations and deliver accurate results.

“Natural State Laboratories and NS Genomics continue to forge the path in the areas of molecular diagnostics and Next Generation Sequencing. Through advancements in technology, we continue to expand genetic testing to uncover potential hereditary disease states by sequencing the genetic code and partnering with the medical community in these areas to enhance the speed and accuracy of diagnosis, while providing a detailed guide map to achieve more efficient therapeutic outcomes,” said Steve Harrison, CEO, Natural State Laboratories.

“These innovative testing facilities provide opportunities to identify mutations and deletions of genes, allowing people to reduce their risk of disease and detect diseases earlier, while providing a personalized treatment plan,” said Senior Producer, Richard Lubin.

About Natural State Labs/Natural State Genomics:

Natural State Laboratories and NS Genomics are state-of-the-art molecular and toxicology laboratories owned by Arkansans and located in Central Arkansas. These laboratories were conceptualized by the desire to make a positive impact on the state and work with physicians, and key opinion leaders in the medical arena to continue to create innovative ways to assist in enhancing patient quality outcomes.

For more information, visit: http://www.naturalstatelaboratories.com.

About Advancements and DMG Productions:

The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more information, please visit http://www.AdvancementsTV.com or call Richard Lubin at 866-496-4065.

Share article on social media or email:

Prevent Blindness Names Marc Ferrara of Jobson Medical Information, as 2021 Person of Vision Award Recipient


Marc Ferrara, CEO of Information Services, Jobson Medical Information, named recipient of the 2021 Prevent Blindness Person of Vision Award.

“Marc Ferrara has been a true leader and influencer in the optical and vision industry for decades,” said Jeff Todd, president and CEO of Prevent Blindness. “We congratulate him on receiving the 2021 Person of Vision Award and look forward to seeing everyone back in New York in May!”

Prevent Blindness, the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight, has chosen Marc Ferrara, CEO of Information Services, Jobson Medical Information, as the recipient of the 2021 Prevent Blindness Person of Vision Award. The award will be presented on Wed., May 26, 2021, at the Prevent Blindness Person of Vision Dinner at 583 Park Avenue, New York, N.Y., in conjunction with Vision Expo East. All proceeds from the event will go to support the sight-saving programs from Prevent Blindness.

The Prevent Blindness Person of Vision Award recognizes an individual or organization whose inspired outlook champions healthy vision and its importance for a healthy life.

Marc Ferrara has worked at Jobson Publishing for more than 30 years. In 1989, he was named editor-in-chief of 20/20 magazine and was later named publisher of the magazine. Later, he helped launch Sightstreet, one of the optical industry’s initial ventures in web-related initiatives, and later managed VisionWeb, the industry’s leading wholesale portal. Mr. Ferrara served as president of JHI’s worldwide Optical Group since 2005, with wide-ranging responsibilities including 20/20, Frames Data, Vision Monday, Review of Optometry, Review of Ophthalmology, Jobson Research, Jobson Internet Solutions and Jobson’s international business in Europe, Latin America and Asia.

At Prevent Blindness, Mr. Ferrara has served on various committees including as Chair of the 2017 Person of Vision Committee, honoring Marge Axelrad, senior vice president, editorial director at Vision Monday/Jobson Optical Group. He has also volunteered for numerous Prevent Blindness events, including the annual Swing Fore Sight golf outings.

“Marc Ferrara has been a true leader and influencer in the optical and vision industry for decades,” said Jeff Todd, president and CEO of Prevent Blindness. “We congratulate him on receiving the 2021 Person of Vision Award and look forward to seeing everyone back in New York in May!”

Sponsorship opportunities are now available. The Prevent Blindness Person of Vision Committee is currently being formed.

For more information including Prevent Blindness Person of Vision Award committee membership, sponsorship opportunities, and reservations, please contact Sue Corbett at (312) 363-6014 or scorbett@preventblindness.org or visit https://preventblindness.org/events/person-of-vision-2021/.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, or to make a contribution to the sight-saving fund, call 1-800-331-2020. Or, visit us on the Web at preventblindness.org or facebook.com/preventblindness.

Share article on social media or email:

iTherapy, LLC receives an Epic MegaGrant to build advanced communication app for non-verbal learners


I believe communication can be mastered if people are provided with the right tools. Lois Brady, CEO iTherapy

iTherapy, LLC, a company that develops immersive educational technology for individuals with communication challenges such as autism, today announced that they have received a MegaGrant from gaming juggernaut Epic Games, creators of Grand Theft Auto and Fortnite. Using the grant, iTherapy will create new software with advanced speech and facial-expression technology, to empower children on the autism spectrum to improve their communication skills and engage with distance learning.

Lois Jean Brady and Matthew Guggemos, the speech-language pathologists at the helm of iTherapy, initially applied for the grant to bring their cutting-edge AI-powered InnerVoice iOS communication app to Android and other platforms. The co-founders have since pivoted to plan a new “edutainment” app, after lockdowns revealed an urgent need for technology allowing children with autism to interact through distance-learning software. Brady explained, “In our first virtual sessions back in March, we found that non-verbal kids on the spectrum didn’t have anything they could interact with, and they were checking out. We realized there needs to be a shared experience between teacher and student, in real time. We thought, let’s take the Epic Games MegaGrant project and create something fun and interactive, where two users can communicate collaboratively.”

As well as using groundbreaking technology from iTherapy’s award-winning InnerVoice app (created with Microsoft’s AI for Accessibility grant), the company’s new app will promote problem-based learning using an entertaining games format, encouraging students around the world to engage with the software on their own. The team at iTherapy believe everyone can master communication, given the right tools, and they are excited about this opportunity to provide non-verbal individuals with a new way to interact and learn to communicate for themselves.

About iTherapy, LLC: iTherapy, LLC is a San Francisco Bay Area company that develops engaging immersive technology which increases quality of life for individuals with communication challenges such as autism. Since 2011, iTherapy has provided thousands of individuals with evidence-based solutions to everyday communication challenges, both through its innovative software and its medical speech therapy clinic, where its speech-language pathologists provide services to a variety of clients. iTherapy’s InnerVoice app has won multiple awards, including the Mensa ERFIB to Society Award in 2013.

Share article on social media or email:

Implications for Clinical Research in a Post-COVID Era, Upcoming Webinar Hosted by Xtalks


The decentralized or virtual research model has become the standard in the current climate and this shift is helping to unlock the promise of telepsychiatry.

Telepsychiatry has always offered a tantalizing solution to the significant undertreatment of mental illness. With COVID-19, widespread stay-at-home measures and reduced offerings for face-to-face mental health services has skyrocketed the demand for in-home care and accelerated the promise of telepsychiatry.

Innovative decentralized or virtual trials are taking telepsychiatry in mental health research to the next level—that is, bringing it to the patient’s home.

During this interactive discussion, panelists will highlight the patient journey for a fully decentralized major depressive disorder (MDD) trial, including methodology for centralized raters, real-time patient dosage monitoring, and patient behavior insights from measured digital biomarkers to evaluate depression. We will also share insights for effective recruitment of a diverse patient population using a digital approach to attract and then engage participants.

The decentralized or virtual research model has become the standard in the current climate and this shift is helping to unlock the promise of telepsychiatry.

Join Thuy Le Nguyen, MPH, Senior Associate Director, Boehringer Ingeheim, Christopher Reist, MD, MBA, Medical Director, Psychiatry and Behavioral Science, Science 37, Isaac Galatzer-Levy, PhD, Chief Scientific Officer, AiCure and Gary Sachs, MD, Clinical Vice President, Signant Health in a live webinar on Friday, October 23, 2020 at 9am EDT (1pm BST/UK).

For more information or to register for this event, visit The Promise of Telepsychiatry: Implications for Clinical Research in a Post-COVID Era.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Jennifer Wong, RPA-C with Advanced Dermatology PC, Offers Tips on Reducing the Hyperpigmentation of Melasma


Jennifer Wong, RPA-C

Fortunately, patients can take action now to reduce the appearance of melasma, as research continues to connect the dots between hormones and other factors.

Blame it on the hormones? Well, maybe. “In some cases,” notes Jennifer Wong, a certified registered physician’s assistant specializing in dermatology with Advanced Dermatology PC, “the dark skin patches called ‘melasma’ occur at the same time a woman experiences hormonal changes. But we’re still learning about the nature of the connection.”

In this country, as many as six million people a year – ninety percent of them women – experience darkened patches of facial skin, usually brown or gray, the result of overproduction of the skin pigment melanin.

“In particular,” says Wong, “women with darker skin tones are more susceptible because their skin has more active melanocytes – the skin cells that produce melanin. Genetics also seems to play a role: having a family member with melasma increases the possibility of developing it yourself.”

And, of course, there is the role of the sun. “The sun triggers our melanocytes,” observes Wong. “With melasma, very little exposure may cause the discoloration. Unlike ‘age spots,’ melasma is not due to cumulative sun, and actually often occurs in young women. In some cases, even the light of our computer or cell screens can contribute to melasma.”

Melasma usually appears on the center forehead, over the brows, on the bridge of the nose, on the chin, and on the upper lip. “All places that get sun exposure,” observes Wong. “In some cases, melasma occurs on other frequently exposed areas like our forearms.”

When melasma co-occurs alongside hormonal changes due to pregnancy, birth control pills, or hormone replacement, it can spontaneously resolve when hormones return to previous levels, for example after the pregnancy or if medications are discontinued. “But in other cases,” notes Wong, “melasma persists. While it is medically harmless, its appearance on one’s face can be distressing. Fortunately, we have a number of options to lighten melasma.”

With that in mind, Wong makes the following suggestions:

5 Tips on Treating Melasma:

1. First, get a clear diagnosis: “It’s important,” says Wong, “to rule out any skin condition that requires medical treatment. A skin specialist can do an examination and, if needed, a biopsy. Once you have a clear diagnosis, you can work with your provider on a treatment plan.”

2. Skin lighteners can help: “In particular,” notes Wong, “topical use of hydroquinone – or HQ – can be effective. HQ comes in varying strengths, including less concentrated over-the-counter formulations, as well as combined with other topicals, such as the retinoid tretinoin and a corticosteroid, in a so-called ‘triple cream.’ Other topical lighteners include azelaic acid and kojic acid. Your skin-care specialist can help guide your choices.”

3. Choose OTC products with care: “An alarming number of OTC skin lighteners contain mercury,” advises Wong, “a neurological toxin that can also injure the children and partners that people come into close contact with. Your skin specialist’s guidance can be especially helpful because some products do not clearly identify ingredients, using different terms for mercury, including calomel, cinnabaris, hydrargyri oxydum rubrum, or quicksilver. In addition to hidden mercury, we’ve also seen products with unlisted steroids, which can cause skin damage.”

4. Outpatient procedures can help, too: “Lasers,” explains Wong, “can penetrate down to melanocytes to block melanin production, while chemical peels can remove hyperpigmented surface skin. Again, your skin specialist can explain outcomes, time involved, and side effects to help customize a treatment plan that is the best fit.”

5. Throw shade on the chance of reoccurrence: “The sun activates our skin’s production of melanin,” notes Wong. “Melasma can be triggered by minimal exposure, regardless of season or weather, so patients will want to be vigilant about protecting themselves from the sun – every day, all year. A broad-spectrum SPF 30 mineral sunscreen with zinc oxide or titanium dioxide can help physically block rays. Patients will also benefit from protective clothing, including a wide-brimmed hat and sunglasses.”

“Fortunately,” Wong concludes, “patients can take action now to reduce the appearance of melasma, as research continues to connect the dots between hormones and other factors.”

Bio: Jennifer M. Wong, RPA-C Physician Assistant. Ms. Wong has comprehensive experience in medical and cosmetic dermatology for all ages.

Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com

Matt Ericksen is Griswold Home Care’s New Director of Sales and Operations


Matt Ericksen has extensive experience in healthcare operations.

“Matt’s expertise will be invaluable in advancing the growth of our franchise system,” said Michael Slupecki, Griswold Home Care CEO.”

Matt Ericksen has joined Griswold Home Care as Director of Sales and Operations. Business development, compliance, and recruitment are his areas of expertise. His addition to Griswold’s operations team demonstrates the home care company’s commitment to growth.

Michael Slupecki, Griswold Home Care CEO, said, “Matt’s expertise will be invaluable in advancing the growth of our franchise system.”

Ericksen earned a BA in American History from Pennsylvania’s East Stroudsburg University in 2010 and has extensive experience in healthcare operations. Most recently, he was Director of Operations at Brightstar Care Inc., where he also served in Executive Director and Client Service Supervisor roles.

About Griswold Home Care

With 200 locations in 30 states, Griswold Home Care is one of the country’s top home care companies, delivering compassionate care 24/7 to its clients. Its purpose is to give people the help they need to live in the place they love. Through this purpose, Griswold Home Care helps adults maintain quality of life despite advanced age or onset of illness through services including companion care, home services, personal care, and respite care. Founded by the late Jean Griswold in 1982, the company has maintained its founder’s profound sense of empathy for older and disabled adults and those living with chronic conditions. For more information, visit http://www.griswoldhomecare.com or call 215.402.0200.

Share article on social media or email: